ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

NCI T Fund New Effort By Cooperative Groups To Extend Treatment Into Community Hospitals

March 5, 1976

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

Russian-American Breast Cancer Meeting Canceled

April 14, 1995

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

January 23, 1976

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003